Part One of Coventry’s 2017 Drug Trends Series reported the largest drop in Morphine Equivalent Dose (MED) in the last three years. As an indicator of increased chances for adverse outcomes, including death from overdose, these and other inroads are essential in the effort to curtail opioid misuse. To learn more about MED and its impact watch our latest video blog.
More stories
Risk & Insurance
In the News
A Breakthrough in Pain Management: Inside the Promise of Journavx
Register Now
Virtual Event
Resilience Redefines Results
On-Demand
Resilience is a powerful factor in improving workers' compensation outcomes, from aiding recovery to enhancing return-to-work success.
Workers' Comp
Case Study
Practical Application of Behavioral Coaching Techniques
Workers' Comp
White Paper
From Setback to Comeback: Effective Solutions for Delayed Recovery
Workers' Comp
Podcast
Pulsing Recovery: Bone Growth Stimulation's Impact on Comp
Workers' Comp
Article
Ask The Pharmacist: FDA Approval of Non-Opioid Medication for Acute Pain
Does Journavx offer a safer alternative to opioids for acute pain relief in workers’ compensation? The